MicroRNA-7 Regulates the mTOR Pathway and Proliferation in Adult Pancreatic β-Cells
暂无分享,去创建一个
Chengyang Liu | A. Naji | D. Stoffers | Jiangying Liu | Ali Naji | Chengyang Liu | You Wang | Doris A. Stoffers | Jiangying Liu | You Wang
[1] D. Stoffers,et al. On the origin of the beta cell. , 2008, Genes & development.
[2] C. Ricordi,et al. Antisense miR-7 Impairs Insulin Expression in Developing Pancreas and in Cultured Pancreatic Buds , 2012, Cell transplantation.
[3] J. Friedman,et al. MicroRNA Profiling Identifies miR-29 as a Regulator of Disease-associated Pathways in Experimental Biliary Atresia , 2012, Journal of pediatric gastroenterology and nutrition.
[4] S. Nagata,et al. Mnk2 and Mnk1 Are Essential for Constitutive and Inducible Phosphorylation of Eukaryotic Initiation Factor 4E but Not for Cell Growth or Development , 2004, Molecular and Cellular Biology.
[5] Anil Bhushan,et al. The replication of beta cells in normal physiology, in disease and for therapy. , 2007, Nature clinical practice. Endocrinology & metabolism.
[6] David Haussler,et al. The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..
[7] K. Takane,et al. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. , 2005, Diabetes.
[8] R. Scharfmann,et al. l-Leucine Alters Pancreatic β-Cell Differentiation and Function via the mTor Signaling Pathway , 2012, Diabetes.
[9] M. Permutt,et al. Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia , 2001 .
[10] John S Mattick,et al. Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.
[11] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[12] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[13] J. Kushner,et al. Very Slow Turnover of β-Cells in Aged Adult Mice , 2005 .
[14] W. Uhl,et al. Partial Pancreatectomy in Adult Humans Does Not Provoke β-Cell Regeneration , 2008, Diabetes.
[15] S. Bonner-Weir,et al. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. , 1995, Transplantation.
[16] M. Behlke,et al. Pancreas-enriched miRNA refines endocrine cell differentiation , 2012, Development.
[17] N. Baroukh,et al. MicroRNA-124a Regulates Foxa2 Expression and Intracellular Signaling in Pancreatic β-Cell Lines* , 2007, Journal of Biological Chemistry.
[18] P. Haentjens,et al. β-Cell Replication Is Increased in Donor Organs From Young Patients After Prolonged Life Support , 2010, Diabetes.
[19] M. Gambello,et al. Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner , 2008, Proceedings of the National Academy of Sciences.
[20] A. F. Stewart,et al. Survey of the Human Pancreatic β-Cell G1/S Proteome Reveals a Potential Therapeutic Role for Cdk-6 and Cyclin D1 in Enhancing Human β-Cell Replication and Function In Vivo , 2009, Diabetes.
[21] E. Izaurralde,et al. Gene silencing by microRNAs: contributions of translational repression and mRNA decay , 2011, Nature Reviews Genetics.
[22] D. Harlan,et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. , 2010, The Journal of clinical endocrinology and metabolism.
[23] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[24] Rika Nakayama,et al. Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic β-Cells Leads to Increased β-Cell Mass and Prevention of Hyperglycemia , 2009, Diabetes.
[25] P. Sharp,et al. MicroRNA functions in stress responses. , 2010, Molecular cell.
[26] Robert A. Rizza,et al. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.
[27] J. Sage,et al. PDGF signalling controls age-dependent proliferation in pancreatic β-cells , 2011, Nature.
[28] L. Rachdi,et al. Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway , 2007, Diabetes, obesity & metabolism.
[29] G. Rutter,et al. miR-29a and miR-29b Contribute to Pancreatic β-Cell-Specific Silencing of Monocarboxylate Transporter 1 (Mct1) , 2011, Molecular and Cellular Biology.
[30] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[31] W. Uhl,et al. Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. , 2008, Diabetes.
[32] J. Kushner,et al. Very slow turnover of beta-cells in aged adult mice. , 2005, Diabetes.
[33] I. Shiojima,et al. mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability* , 2009, Journal of Biological Chemistry.
[34] M. Birnbaum,et al. Three-amino-acid-loop-extension homeodomain factor Meis3 regulates cell survival via PDK1 , 2010, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Mcdaniel,et al. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. , 2004, Diabetes.
[36] M. Permutt,et al. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. , 2001, The Journal of clinical investigation.
[37] Michael T. McManus,et al. MicroRNA Expression Is Required for Pancreatic Islet Cell Genesis in the Mouse , 2007, Diabetes.
[38] C. Ricordi,et al. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. , 2009, Gene expression patterns : GEP.
[39] Y. Dor,et al. miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors , 2011, The EMBO journal.
[40] A. Kolokythas,et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. , 2010, The Biochemical journal.
[41] Dudley Lamming,et al. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.
[42] Ming Yi,et al. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. , 2011, Cancer research.
[43] M. Büchler,et al. Impaired islet turnover in human donor pancreata with aging. , 2008, European journal of endocrinology.
[44] Ling Tian,et al. MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma , 2012, Hepatology.
[45] Selene L. Fernandez-Valverde,et al. MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications , 2011, Diabetes.
[46] N. Rajewsky,et al. A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.
[47] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[48] C. Ricordi,et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. , 2008, Biochemical and biophysical research communications.
[49] P. Halban,et al. Proliferation of sorted human and rat beta cells , 2007, Diabetologia.
[50] Yunqing Li,et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.
[51] J. Rinn,et al. Non-coding RNAs as regulators of embryogenesis , 2011, Nature Reviews Genetics.
[52] S. Pyronnet,et al. Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. , 2000, Biochemical pharmacology.
[53] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..